Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

RPR's Gliadel Wafer approved in Argentina

April 20, 1998

P&U claims new distamycin derivatives and their use as antitumor and antiviral agents

April 20, 1998

Synthetic dolastatin derivatives as antitumor agents

April 20, 1998

Idun seeks licensing partners for apoptosis regulators

April 20, 1998

SuperGen's Nipent granted orphan drug status

April 17, 1998

Another CS-A4 derivative discovered by Ajinomoto

April 17, 1998

Novel polymer chemotherapeutic presented at ACS meeting

April 17, 1998

Varian and GenVec collaborate on novel cancer treatments

April 17, 1998

Theratechnologies receives additional funding for photodynamic therapy research

April 17, 1998

Selective MMP-13 inhibitors in the pipeline at Monsanto

April 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...